Cristina Puig-Saus and Daniel Shin, of UCLA Jonsson Comprehensive Cancer Center have received a $1 million Translational Research Award from the U.S. Department of Defense Melanoma Research Program to help advance the use of chimeric antigen receptor, or CAR, T cell therapy as a treatment for people with acral, mucosal and uveal melanomas.
The first UAMS Baptist Health Cancer Center is now open on the campus of Baptist Health Medical Center in North Little Rock.
Stand Up To Cancer and Jazz Pharmaceuticals have entered into a three-year, $4 million research collaboration to research hard-to-treat cancers, including lurbinectedin in pediatric solid tumors and pan-RAF molecules in RAF- and RAS-mutated solid cancers.
The Cancer Prevention and Research Institute of Texas has awarded 73 new cancer research and prevention grants totaling over $142 million.
The Cancer Prevention and Research Institute of Texas has awarded eight grants totaling more than $13 million dedicated to expanding access to cancer clinical trials in Texas, including one new award that will strengthen clinical trial network infrastructure, two first-of-their-kind CPRIT awards to encourage increased participation in clinical trials and five awards that support the next generation of promising clinical investigators.
The Office of Inspector General issued a review of FDA’s Accelerated Approval pathway.
Jim Gabriele was named president and chief executive officer of M2GEN.
Memorial Sloan Kettering Cancer Center has established MSKCC India to provide cancer patients in India with access to the institution’s oncologists, research, clinical trials, and education.
Researchers from Queen’s University Belfast, the Northern Ireland Cancer Registry, the International Agency for Research on Cancer and the Union for International Cancer Control have developed CanStaging+, a user-friendly tool aimed at facilitating the recording of comparable cancer staging data worldwide.
Lakshmanan Krishnamurti was named chief of pediatric hematology, oncology, and bone marrow transplant at Yale New Haven Children’s Hospital and Leader of the Smilow Cancer Hospital Pediatric Hematology/Oncology Program.
